The proteins encoded by the overexpressed genes can serve as therapeutic targets, as we have demonstrated using SeChry, a well-tolerated compound by noncancer cells and an effective cytotoxic and growth controller in NSCLC depending on CBS activity, such as A549 and H292 cell lines. Here, CBS is linked to non-small cell lung carcinoma.